Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson's disease: A randomized clinical trial

Malling ASB, Morberg BM, Wermuth L, Gredal O, Bech P, Jensen BR.

PLoS One. 2018 Sep 25;13(9):e0204478. doi: 10.1371/journal.pone.0204478. eCollection 2018.

Occupancy of adenosine A(2A) receptors by istradefylline in patients with Parkinson's disease using (11)C-preladenant PET

Ishibashi K, Miura Y, Wagatsuma K, Toyohara J, Ishiwata K, Ishii K.

Neuropharmacology. 2018 Dec;143:106-112. doi: 10.1016/j.neuropharm.2018.09.036. Epub 2018 Sep 22.

Parkinson's disease: Cause factors, measurable indicators, and early diagnosis

Bhat S, Acharya UR, Hagiwara Y, Dadmehr N, Adeli H.

Comput Biol Med. 2018 Nov 1;102:234-241. doi: 10.1016/j.compbiomed.2018.09.008. Epub 2018 Sep 20.

Optimizing Clinical Assessments in Parkinson's Disease Through the Use of Wearable Sensors and Data Driven Modeling

Ramdhani RA, Khojandi A, Shylo O, Kopell BH.

Front Comput Neurosci. 2018 Sep 11;12:72. doi: 10.3389/fncom.2018.00072. eCollection 2018.

Are We Doing More Than We Know? Possible Mechanisms of Response to Music Therapy

Clements-Cortes A, Bartel L.

Front Med (Lausanne). 2018 Sep 11;5:255. doi: 10.3389/fmed.2018.00255. eCollection 2018.

A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?

Hiller AL, Murchison CF, Lobb BM, O'Connor S, O'Connor M, Quinn JF.

PLoS One. 2018 Sep 26;13(9):e0203637. doi: 10.1371/journal.pone.0203637. eCollection 2018.

Deconstructing and targeting the genomic architecture of human neurodegeneration

De Jager PL, Yang HS, Bennett DA.

Nat Neurosci. 2018 Oct;21(10):1310-1317. doi: 10.1038/s41593-018-0240-z. Epub 2018 Sep 26.

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Jucker M, Walker LC.

Nat Neurosci. 2018 Oct;21(10):1341-1349. doi: 10.1038/s41593-018-0238-6. Epub 2018 Sep 26.

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis

Butkovich LM, Houser MC, Tansey MG.

Front Neurosci. 2018 Sep 11;12:626. doi: 10.3389/fnins.2018.00626. eCollection 2018.

3D tissue engineering, an emerging technique for pharmaceutical research

Jensen G, Morrill C, Huang Y.

Acta Pharm Sin B. 2018 Sep;8(5):756-766. doi: 10.1016/j.apsb.2018.03.006. Epub 2018 Mar 21.

Circular RNA and Alzheimer's Disease

Akhter R.

Adv Exp Med Biol. 2018;1087:239-243. doi: 10.1007/978-981-13-1426-1_19.

[Confusion, loss of consciousness and unspecific visual hallucinations may be symptoms of dementia with Lewy bodies]

Dombernowsky NW, Law I, Hasselbalch SG.

Ugeskr Laeger. 2018 Sep 17;180(38):V04180305.

Ageing, Cellular Senescence and Neurodegenerative Disease

Kritsilis M, V Rizou S, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D.

Int J Mol Sci. 2018 Sep 27;19(10):2937. doi: 10.3390/ijms19102937.

Pharmacokinetic Enhancers (Boosters)-Escort for Drugs against Degrading Enzymes and Beyond

Krauß J, Bracher F.

Sci Pharm. 2018 Sep 27;86(4):E43. doi: 10.3390/scipharm86040043.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias